BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25446900)

  • 1. Rab1A is an mTORC1 activator and a colorectal oncogene.
    Thomas JD; Zhang YJ; Wei YH; Cho JH; Morris LE; Wang HY; Zheng XF
    Cancer Cell; 2014 Nov; 26(5):754-69. PubMed ID: 25446900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A.
    Xu BH; Li XX; Yang Y; Zhang MY; Rao HL; Wang HY; Zheng XF
    Oncotarget; 2015 Aug; 6(25):20813-28. PubMed ID: 26308575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer.
    Fan SJ; Snell C; Turley H; Li JL; McCormick R; Perera SM; Heublein S; Kazi S; Azad A; Wilson C; Harris AL; Goberdhan DC
    Oncogene; 2016 Jun; 35(23):3004-15. PubMed ID: 26434594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer.
    Cheng Z; Shao X; Xu M; Wang J; Kuai X; Zhang L; Wu J; Zhou C; Mao J
    Oncol Rep; 2019 May; 41(5):2717-2728. PubMed ID: 30896866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gankyrin activates mTORC1 signaling by accelerating TSC2 degradation in colorectal cancer.
    Qin X; Wang X; Liu F; Morris LE; Wang X; Jiang B; Zhang Y
    Cancer Lett; 2016 Jun; 376(1):83-94. PubMed ID: 26975632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rab1A knockdown represses proliferation and promotes apoptosis in gastric cancer cells by inhibition of mTOR/p70S6K pathway.
    Li Z; Li Y; Jia Y; Ding B; Yu J
    Arch Biochem Biophys; 2020 May; 685():108352. PubMed ID: 32240637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression analysis and implication of Rab1A in gastrointestinal relevant tumor.
    Xu M; Shao X; Kuai X; Zhang L; Zhou C; Cheng Z
    Sci Rep; 2019 Sep; 9(1):13384. PubMed ID: 31527621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTORC1 gRABs the Golgi.
    Sanchez-Gurmaches J; Guertin DA
    Cancer Cell; 2014 Nov; 26(5):601-3. PubMed ID: 25517745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth.
    Zha X; Hu Z; Ji S; Jin F; Jiang K; Li C; Zhao P; Tu Z; Chen X; Di L; Zhou H; Zhang H
    Cancer Lett; 2015 Apr; 359(1):97-106. PubMed ID: 25578782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
    Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X
    Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Rab1A is upregulated in human lung cancer and associated with tumor size and T stage.
    Wang X; Liu F; Qin X; Huang T; Huang B; Zhang Y; Jiang B
    Aging (Albany NY); 2016 Nov; 8(11):2790-2798. PubMed ID: 27902464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
    Mi W; Ye Q; Liu S; She QB
    Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rab1A promotes IL-4R/JAK1/STAT6-dependent metastasis and determines JAK1 inhibitor sensitivity in non-small cell lung cancer.
    Huang T; Chen B; Wang F; Cai W; Wang X; Huang B; Liu F; Jiang B; Zhang Y
    Cancer Lett; 2021 Dec; 523():182-194. PubMed ID: 34627950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between optineurin and Rab1a regulates autophagosome formation in neuroblastoma cells.
    Song GJ; Jeon H; Seo M; Jo M; Suk K
    J Neurosci Res; 2018 Mar; 96(3):407-415. PubMed ID: 28843006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia.
    Gao Y; Gao J; Li M; Zheng Y; Wang Y; Zhang H; Wang W; Chu Y; Wang X; Xu M; Cheng T; Ju Z; Yuan W
    J Hematol Oncol; 2016 Apr; 9():36. PubMed ID: 27071307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
    Wang YY; Lv YF; Lu L; Cai L
    Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rab1 GTPases as oncogenes.
    Li Y; Wang HY; Zheng XF
    Aging (Albany NY); 2015 Nov; 7(11):897-8. PubMed ID: 26590354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.